20 studies found for:    Dravet Syndrome
Show Display Options
Rank Status Study
1 Available Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
Conditions: Dravet Syndrome;   Epileptic Encephalopathies Associated With SCN1A Mutations
Intervention: Drug: Stiripentol
2 No longer available Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: stiripentol
3 Available Compassionate Use of Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
4 Available Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
5 Completed Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Verapamil
6 Completed Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
7 Completed A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
8 Recruiting A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
9 Terminated Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Clobazam
10 Withdrawn Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: Clobazam;   Drug: Placebo
11 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCL) in Children and Young Adults With Dravet Syndrome
Conditions: Dravet Syndrome;   Seizure Disorder
Interventions: Drug: ZX008 (Fenfluramine Hydrochloride);   Drug: Matching Placebo
12 Not yet recruiting Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: Cannabidiol Oral Solution;   Drug: Placebo Solution
13 Recruiting Cardiac Arrhythmias in Dravet Syndrome
Condition: Epilepsy
Intervention:
14 Recruiting Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population
Condition: Dravet Syndrome
Intervention:
15 Not yet recruiting Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome
Condition: Epilepsy
Interventions: Drug: ataluren;   Drug: Placebo
16 Recruiting Genetics of Severe Early Onset Epilepsies
Conditions: Epilepsy;   Epileptic Encephalopathy;   Ohtahara Syndrome;   Infantile Spasms;   Dravet Syndrome;   Malignant Migrating Partial Epilepsy of Infancy;   Early Myoclonic Epileptic Encephalopathy
Intervention:
17 Enrolling by invitation Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
Condition: Seizures
Intervention: Drug: Cannabidiol Oral Solution
18 Enrolling by invitation An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
Conditions: Epilepsy;   Dravet Syndrome;   Lennox-Gastaut Syndrome
Intervention: Drug: GWP42003-P
19 Active, not recruiting Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
Condition: Epilepsy
Intervention: Drug: Cannabidiol
20 Recruiting Risk Factors for Sudden Unexplained Death in Epilepsy
Condition: SUDEP
Intervention:

Indicates status has not been verified in more than two years